Found 10 results
Author [ Title(Desc)] Type Year
Filters: Author is Tripathy, Sasmita  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Y. Wang, Torres-Gonzalez, M., Tripathy, S., Botolin, D., Christian, B., and Jump, D. B., “Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.”, J Lipid Res, vol. 49, no. 7, pp. 1538-52, 2008.
S. Tripathy, Torres-Gonzalez, M., and Jump, D. B., “Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.”, Journal of lipid research, vol. 51, no. 9, pp. 2642-54, 2010.
S. Tripathy and Jump, D. B., “Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.”, Journal of lipid research, vol. 54, no. 1, pp. 71-84, 2013.
F
S. Tripathy, Lytle, K. A., Stevens, R. D., Bain, J. R., Newgard, C. B., Greenberg, A. S., Huang, L. - S., and Jump, D. B., “Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.”, Journal of lipid research, vol. 55, no. 7, pp. 1448-1464, 2014.
D. B. Jump, Tripathy, S., and Depner, C. M., “Fatty acid-regulated transcription factors in the liver.”, Annu Rev Nutr, vol. 33, pp. 249-69, 2013.
I
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., “Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.”, Proc Nutr Soc, vol. 75, no. 1, pp. 1-9, 2016.
M
C. M. Depner, Torres-Gonzalez, M., Tripathy, S., Milne, G., and Jump, D. B., “Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.”, The Journal of nutrition, vol. 142, no. 8, pp. 1495-503, 2012.
O
D. B. Jump, Depner, C. M., and Tripathy, S., “Omega-3 fatty acid supplementation and cardiovascular disease.”, Journal of lipid research, vol. 53, no. 12, pp. 2525-45, 2012.
D. B. Jump, Lytle, K. A., Depner, C. M., and Tripathy, S., “Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.”, Pharmacol Ther, vol. 181, pp. 108-125, 2018.
P
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., “Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.”, Advances in nutrition (Bethesda, Md.), vol. 6, no. 6, pp. 694-702, 2015.